Clinical Trials
28 trialsAn Investigation of Pituitary Tumors and Related Hypothalmic Disorders
National Institutes of Health Clinical Center (CC)
Long Term Outcome Study in Patients With Pituitary Disorders
University of Alberta
SPARAGMOS
University of Sao Paulo General Hospital
OEMacroPrL
Hospices Civils de Lyon
The PROMISE Survey
University Hospital, Basel, Switzerland
Prolac-10
Ohio State University
ProBOLIC
University Hospital, Basel, Switzerland
Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole
Columbia University
Exercise Capacity and Physical Activity Level in Prolactinoma Patients
Hacettepe University
Temozolomide in Treating Patients With Invasive Pituitary Tumors
Jonsson Comprehensive Cancer Center
PRolaCT - Three Prolactinoma RCTs
Leiden University Medical Center
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
Seoul National University Hospital
SNU-PIT
Seoul National University Hospital
Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Cedars-Sinai Medical Center
Dopamine D2 Receptors(D2R) Imaging in Prolactinomas
Ruijin Hospital
Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas
Ruijin Hospital
Rhinological Outcomes in Endonasal Pituitary Surgery
St. Joseph's Hospital and Medical Center, Phoenix
TNAPA
First Affiliated Hospital, Sun Yat-Sen University
Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus
Ruijin Hospital
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
Universidade Federal do Rio de Janeiro
PITUICARE-Lyon
Hospices Civils de Lyon
Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Unity Health Toronto
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
National Cancer Institute (NCI)
Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
Cedars-Sinai Medical Center
Efficacy of Rapid Escalation of Cabergoline in Comparison to Conventional Dosing in Prolactin Secreting Macroadenomas.
PIMERIndia
Clomiphene in Males With Prolactinomas and Persistent Hypogonadism
Federal University of São Paulo
ValveCab
Federico II University
Insulin Resistance in Women With Prolactinoma
Universidade Federal do Rio de Janeiro